Sign Up

KITS Eyecare Announces Revised Q1 2025 Guidance, Anticipates Higher Adjusted EBITDA Than Previously Forecasted

Company Now Expects Adjusted EBITDA as a Percentage of Revenue between 6% and 8%, Exceeding the Previous Guidance of 4% to 6%.

VANCOUVER, BC, March 17, 2025 /CNW/ - Kits Eyecare Ltd. (TSX:KITS) ("KITS" or the "Company"), a leading vertically integrated eyecare provider, announces an upward revision to the Company's Q1 2025 Adjusted EBITDA guidance. The Company now expects Q1 Adjusted EBITDA of approximately 6% to 8%, exceeding the previously guided range of 4% to 6%.

Updated First Quarter 2025 OutlookFor the first quarter of 2025, KITS management has increased their Adjusted EBITDA target range of 6% to 8%, an increase from the initial range of 4% to 6%. Forecasted revenue remains between $46 million to $48 million, representing a 32% to 38% growth rate year-over-year.  See "Forward-Looking Statements" below for important disclosure with respect to expectations and forward-looking information.

Management Commentary"We are pleased to increase our guidance for Adjusted EBITDA from 4-6% to 6-8%, reflecting the strength of our business model and the continued momentum across our key growth drivers," said Roger Hardy, CEO and Co-Founder of KITS. "We are seeing significant traction in new glasses customers as our latest collections resonate with first-time buyers and drive repeat purchases among existing customers. Consumption per customer remains strong as customers recognize the quality and value of our offering. As we continue to scale, we remain focused on delivering exceptional value to our customers while driving sustainable, margin-accretive growth for our shareholders."

This revision aligns with our ongoing strategy to deliver consistent growth and operational excellence while maintaining transparency ...